• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The effect of mildronate and related substances on levels of thyroid hormones and some intermediates of lipid and carbohidrate metabolism in the hyperthyroid and hypothyroid rats].

作者信息

Sharipova E M, Salna E V, Dzintare M I, Lauberte L I, Sjakste N I, Gordiushina V S, Kalvinsh I I

出版信息

Biomed Khim. 2007 Nov-Dec;53(6):672-82.

PMID:18323152
Abstract

We have investigated effects of Mildronate, gamma-butyrobetaine (GBB) and their combination ("Neomildronate") on the plasma levels of thyroid gland hormones and some intermediates of basal metabolism (free fatty acids, triglycerides, glucose) in rats with different dysfunctions of thyroid gland, including idiopathic hyperfunction and hypofunction induced by propylthiouracil or L-carnitin administration. Histological investigation of the thyroid gland was also performed. Intraperitoneal injections of Mildronate (150 mg/kg) during 20 days to Wistar male rats with elevated level of thyroid hormones and basal metabolism normalized thyroxine level and parameters of lipid metabolism. Mildronate, GBB and their combination did not affect the natural resurgence of rats with experimental hypofunction induced by propylthiouracil or L-carnitin administration. The possible biochemical role of given treatment in regulation of thyroid gland function is discussed.

摘要

相似文献

1
[The effect of mildronate and related substances on levels of thyroid hormones and some intermediates of lipid and carbohidrate metabolism in the hyperthyroid and hypothyroid rats].
Biomed Khim. 2007 Nov-Dec;53(6):672-82.
2
Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.米屈肼,一种肉碱生物合成抑制剂,可使γ-丁酸甜菜碱含量增加,并对离体大鼠心脏梗死产生心脏保护作用。
J Cardiovasc Pharmacol. 2006 Dec;48(6):314-9. doi: 10.1097/01.fjc.0000250077.07702.23.
3
Elevated vascular γ-butyrobetaine levels attenuate the development of high glucose-induced endothelial dysfunction.血管中γ-丁酰甜菜碱水平升高可减轻高糖诱导的内皮功能障碍的发展。
Clin Exp Pharmacol Physiol. 2013 Aug;40(8):518-24. doi: 10.1111/1440-1681.12127.
4
The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.美曲肼的心脏保护作用在与左旋肉碱联合治疗后减弱。
J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):215-22. doi: 10.1177/1074248411419502. Epub 2011 Sep 8.
5
Effects of long-term mildronate treatment on cardiac and liver functions in rats.长期使用米屈肼对大鼠心、肝功能的影响。
Basic Clin Pharmacol Toxicol. 2009 Dec;105(6):387-94. doi: 10.1111/j.1742-7843.2009.00461.x. Epub 2009 Aug 5.
6
Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.美替诺龙治疗改变健康志愿者中γ-丁羟丁酸盐和左旋肉碱的浓度。
J Pharm Pharmacol. 2011 Sep;63(9):1195-201. doi: 10.1111/j.2042-7158.2011.01325.x. Epub 2011 Jul 6.
7
Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
Eur J Pharmacol. 2004 Jul 8;495(1):67-73. doi: 10.1016/j.ejphar.2004.05.006.
8
Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.米屈肼,一种能量代谢调节剂,可减轻载脂蛋白E/低密度脂蛋白受体基因双敲除小鼠的动脉粥样硬化。
Pharmacology. 2009;83(5):287-93. doi: 10.1159/000210015. Epub 2009 Mar 27.
9
[The effect of the carnitine biosynthesis inhibitor mildronate on the lipid metabolic indices of rats].[肉碱生物合成抑制剂米多君对大鼠脂质代谢指标的影响]
Farmakol Toksikol. 1991 Mar-Apr;54(2):55-6.
10
Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life.给予米屈膦酸盐的母鼠所产幼鼠的肉碱缺乏:胎儿晚期和新生儿期肉碱缺乏的模型
Life Sci. 2005 Oct 28;77(24):3078-91. doi: 10.1016/j.lfs.2005.03.029. Epub 2005 Jun 24.